2nd Quarter - Report

ARENTFOX SCHIFF LLP for ORGANOGENESIS INC.

Firm
Client
Income
—
Expenses
—

No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Food and Drug Administration policy on chronic wound healing products Food and Drug Administration user fee policy S. 934 (Prescription Drug User Fee Amendments of 2017), all provisions H.R. 2430 (FDA Reauthorization Act of 2017), all provisions

LobbyistCovered position, as disclosed
JAMES RAVITZ —
DAN RENBERG —

Contacted: SENATE

Bills named: S. 934 (115th), H.R. 2430 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.